SCHEMBL17655428

SCHEMBL17655428

Cc1cnccc1NC(N)=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT3 Q9NTG7 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
POLB P06746 2/20 0.46
IMPDH2 P12268 1/20 0.43
CCNC P24863 2/20 0.42
CDK8 P49336 2/20 0.42
IL2 P60568 1/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
ALDH1A1 P00352 4/20 0.41
LMNA P02545 1/20 0.41
PKM P14618 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
KDM4E B2RXH2 1/20 0.40
IKBKE Q14164 1/20 0.40
TBK1 Q9UHD2 1/20 0.40
HPGD P15428 1/20 0.40
MAPT P10636 1/20 0.40
KMT2A Q03164 1/20 0.40
IRAK4 Q9NWZ3 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27684513 0.85 SIRT3 (0.55) SIRT3TDP1POLBIMPDH2NPC1
SCHEMBL1043517 0.85 KDM4C (0.46) SIRT3TDP1IMPDH2IL2NPC1
SCHEMBL9413722 0.84 KDM4C (0.46) SIRT3TDP1POLBNPC1RAB9A
SCHEMBL4139383 0.83 ALDH1A1 (0.55) SIRT3TDP1IMPDH2IL2NPC1
SCHEMBL11918912 0.81 MAPT (0.46) SIRT3TDP1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL15432258 0.80 HPGD (0.49) SIRT3TDP1IL2NPC1RAB9A
SCHEMBL15432259 0.80 IDO1 (0.44) SIRT3TDP1IMPDH2NPC1RAB9A
SCHEMBL19151050 0.79 ALDH1A1 (0.46) NPC1RAB9AALDH1A1LMNAPKM
SCHEMBL16303157 0.79 MDM4 (0.46) IMPDH2NPC1RAB9ALMNASMN1; SMN2
SCHEMBL5455951 0.79 IL2 (0.40) SIRT3TDP1IMPDH2IL2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3224252-A1 SUBSTITUTED OXAZOLE- AND THIAZOLE-BASED CARBOXAMIDE AND UREA DERIVATIVES AS VANILLOID RECEPTOR LIGANDS II MEDIFRON DBT INC. (KR) 2017-10-04 EP disclosed
WO-2016082930-A1 SUBSTITUTED OXAZOLE- AND THIAZOLE-BASED CARBOXAMIDE AND UREA DERIVATIVES AS VANILLOID RECEPTOR LIGANDS II Grünenthal GmbH (DE) 2016-06-02 WO disclosed
EP-2493888-B1 BICYCLIC PYRIDINES AND ANALOGS AS SIRTUIN MODULATORS GLAXOSMITHKLINE LLC (US) 2016-04-06 EP disclosed